Meeting/Event Information

Presentation Overview

Complicated urinary tract infections (UTIs) pose ongoing challenges in clinical management due to their diverse presentations and patient populations. In this session, we’ll tackle some of the most debated aspects of care, including how to choose appropriate empiric therapy, determine optimal treatment duration, and make evidence-based decisions about switching from IV to oral antibiotics. Join us as we navigate these complex issues with a practical, case-based approach.

Learning Objectives

1) Understand clinically relevant classifications of urinary tract infections.

2) Apply a structured 4-step approach to selecting empiric antimicrobial therapy.

3) Appreciate the nuances and evolving evidence around appropriate duration of therapy.

Agenda

5:45 PM: Reception Meet & Greet with industry supporters
6:45 PM: Served Buffet & Meeting Commences

Presenter

Barbara W. Trautner, MD, PhD

Barbara W. Trautner, MD, PhD will be joining WashU Medicine as the new Co-Chief of the Infectious Diseases (ID) Division in the Department of Medicine, effective July 1, 2025. Dr. Trautner is currently a Professor of Medicine and Surgery at Baylor College of Medicine in Houston, Texas, and a physician at the Houston Michael E. DeBakey Veterans Affairs Medical Center.

Dr. Trautner’s research focuses on diagnostic and antibiotic stewardship, particularly for urinary tract infections (UTIs). She has led trials to disseminate successful antibiotic stewardship interventions, improve the diagnosis and treatment of UTIs in men, develop bacteriophage therapy for UTIs in individuals with spinal cord injuries, and to reduce overdiagnosis of catheter-associated UTI. She serves as a reviewer for the NIH and for VA Health Systems Research Merit Awards. She is also an author for UpToDate on catheter-associated UTIs and prostatitis. Additionally, she serves as the co-chair of the Infectious Diseases Society of America’s Guidelines Committee for UTIs and is recognized nationally and internationally as an expert in the prevention, diagnosis, and treatment of UTIs, as well as in antimicrobial stewardship and the prevention of antimicrobial resistance. She is an extremely active clinical and translational investigator, a passionate educator, and a caring and dedicated clinician. She has been a mentor to many medical students, residents, and fellows. She fostered an outstanding culture and climate at Baylor and the VA to support clinical and translational research and faculty development.

Target Audience

This course is directed to infectious diseases physicians, pediatricians, public health specialists, infection control specialists, epidemiologists, and those who oversee infection control programs. Fellows are always welcome at no charge.

Contact

If you have any questions please email [email protected].